section of webpage -->


Cardiac electrophysiology is the study and treatment of abnormal electrical heart rhythms (arrhythmia).

The Electrophysiology / Arrhythmia service at MHVI delivers the latest in diagnostic and therapeutic offerings for heart rhythm management. These include pacemaker and defibrillator implantation, devices to treat congestive heart failure, catheter ablation to treat heart rhythm conditions.

We offer state-of-the-art treatments like left atrial appendage occlusion (Watchman) devices, leadless pacemakers, subcutaneous defibrillators, and atrial fibrillation ablation (pulmonary vein isolation). We have an active catheter ablation program to treat heart rhythm conditions such as atrial fibrillation and flutter, supraventricular tachycardias, Wolff-Parkinson-White syndrome, ventricular tachycardia, and other complex arrhythmias that may sometimes be difficult to treat with conventional medical therapies.  We employ various modalities, including cryoablation and radiofrequency ablation to tackle difficult to treat conditions such as atrial fibrillation.

MHVI offers an excellent cardiac rhythm device program for patients with primary arrhythmia, genetic disorders, and congestive heart failure, who require or benefit from ongoing device therapy. We are engaged in clinical research trials to deliver new cutting edge therapies for our patients.

At MHVI we provide state-of-the-art, patient-centered care that is delivered with quality, proximity, and personal attention.  This means that patients treated with a biventricular defibrillator for advanced congestive heart failure or complex catheter ablation for atrial fibrillation can receive their pre-procedure care and post-procedure follow up close to their home, by providers who know them well. Patients and their families who choose MHVI expect and receive not just clinical expertise, but continuity and familiarity from their heart rhythm providers and proceduralists.

Atrial Fibrillation Ablation.  Learn more.

Leadless Pacemaker.  Learn more.

Subcutaneous Implantable Cardioverter-Defibrillator

© Metropolitan Heart Vascular Institute